COVID-19 Epidemic in Argentina: Worsening of Behavioral Symptoms in Elderly Subjects With Dementia Living in the Community by Cohen, Gabriela et al.
Frontiers in Psychiatry | www.frontiersin.or
Edited by:
Gianfranco Spalletta,
Santa Lucia Foundation (IRCCS), Italy
Reviewed by:
Raquel Luiza Santos,
Federal University of Rio de Janeiro,
Brazil
Chin Yee Cheong,





This article was submitted to
Aging Psychiatry,
a section of the journal
Frontiers in Psychiatry
Received: 30 June 2020
Accepted: 10 August 2020
Published: 28 August 2020
Citation:
Cohen G, Russo MJ, Campos JA and
Allegri RF (2020) COVID-19 Epidemic
in Argentina: Worsening of Behavioral
Symptoms in Elderly Subjects With




published: 28 August 2020
doi: 10.3389/fpsyt.2020.00866COVID-19 Epidemic in Argentina:
Worsening of Behavioral Symptoms
in Elderly Subjects With Dementia
Living in the Community
Gabriela Cohen*, Marı́a Julieta Russo, Jorge A. Campos and Ricardo F. Allegri
Memory and Ageing Center, Department of Cognitive Neurology, Neuropsychiatry and Neuropsychology, Fleni. Fundación
para el estudio de enfermedades neurológicas de la infancia, Buenos Aires, Argentina
In Argentina, the quality of care that elderly subjects with dementia living in the community
received has been deeply affected by COVID-19 epidemic. Our objective was to study to
what extend mandatory quarantine imposed due to COVID-19 had affected behavioral
symptoms in subjects with dementia after the first 8 weeks of quarantine. We invited family
members to participate in a questionnaire survey. The sample consisted of family
caregivers (n = 119) of persons with AD or related dementia living at home. We
designed a visual analog scale to test the level of the burden of care of family members.
Items inquired in the survey included type and setting (home or day care center) of
rehabilitation services (physical/occupational/cognitive rehabilitation) and change in
psychotropic medication and in behavioral symptoms that subjects with dementia
experienced before and during the epidemic. Characteristics of people with dementia
and their caregivers were analyzed with descriptive statistics using the chi-square tests,
p < 0.01 was considered significant. Results: The sample included older adults with
dementia. Mean age: 81.16 (±7.03), 35% of the subjects had more than 85 years of age.
Diagnosess were 67% Alzheimer´s dementia and 26% mixed Alzheimer´s disease (AD).
Stages were 34.5% mild cases, 32% intermediate stage, and 33% severe cases as per
Clinical dementia Rating score. In 67% of the sample, a family member was the main
caregiver. Important findings were increased anxiety (43% of the sample), insomnia (28%
of the subjects), depression (29%), worsening gait disturbance (41%), and increase use of
psychotropics to control behavioral symptoms. When we compared the frequency of
behavioral symptoms within each dementia group category, we found that anxiety,
depression, and insomnia were more prevalent in subjects with mild dementia
compared to subjects with severe dementia. We analyzed the type and pattern of use
of rehabilitation services before and during the isolation period, and we observed that, as a
rule, rehabilitation services had been discontinued in most subjects due to the quarantine.
We concluded from our analysis that during COVID-19 epidemic there was a deterioration
of behavioral symptoms in our population of elderly dementia subjects living in the
community. Perhaps, our findings are related to a combination of social isolation, lack
of outpatient rehabilitation services, and increased stress of family caregivers. It isg August 2020 | Volume 11 | Article 8661
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stress that this epidemic imposed on them.Keywords: dementia, behavioral symptoms, COVID-19 epidemic, quarantine, elderlyINTRODUCTION
The World Health Organization declared the COVID-19
epidemic on March 11 (1). A few days later, and with the
experience of how the epidemic was affecting countries in
Europe and Asia, the Argentinian Government issued an
executive order implementing a complete lockdown and
isolation of travelers returning from the affected countries (2).
Non-essential business was closed, and people were asked to
avoid unnecessary travel to maintain social distance and to limit
family visits to elderly subjects (2). At the time of writing this
communication, quarantine in Buenos Aires had lasted 101 days,
the number of deceased people in the entire country had reached
1,245, and the number of infected persons is 59,933 (3).
Governments through the world were challenged to deal with
both the direct impact of the disease on the health system and the
economic, financial, and social consequences of the epidemic.
Worldwide health authorities also need to design models of care
of chronic conditions not related to COVID-19 in times of this
epidemic (3).
Alzheimer`s disease (AD) and related disorders subjects are
especially vulnerable to the effects of COVID-19 disease and the
imposed quarantine (4, 5). Based on frequent comorbidities and
older age, they might be at higher risk for severe illness from
COVID-19 (5–7). For example, in Italy, dementia was one of the
most frequent comorbidities present in 12% of the deceased
COVID-19 patients (8). On the other hand, dementia subjects
are also extremely vulnerable to the effects of enforced
quarantine (9). They depend strongly on community and
social support systems for survival due to the dependence on
activities of daily living (10). They may not learn properly the use
personal protection elements, such as wearing facial masks,
washing hands, and keeping social distance, and may forget to
avoid leaving their home unnecessarily. They are probably be less
flexible on coping with changing situations and during crisis, and
they rely more on family members. However, during this
epidemic, family members are trying to limit contact with
elderly dementia subjects to decrease as much as possible the
risk of coronavirus transmission. While during this epidemic
virtual technology is playing a central role in preventing isolation
in the general population, this vital resource is sometimes
difficult to utilize for dementia subjects due to their difficulties
to learn the use of this technology (9–12).
As suggested by the Alzheimer`s International Society,
support for subjects living with dementia and their caregivers
is mandatory (11). Access to care for family members and
dementia subjects in order to deal with a new situation is
critical (8) and mitigation strategies to reduce the immediate
and long-term impact of this health crisis are needed (4). For
example, in Australia, the Health Department quickly realizedg 2the need for improved access to mental healthcare services for
older people during COVID-19 times (13). While during this
epidemic virtual technology is playing a central role in
preventing isolation, this vital resource is difficult to utilize on
dementia subjects due to their difficulties to learn the use of this
technology (9–12).
To prepare a rational plan to mitigate the effects of the
epidemic, it is necessary first to identify in our setting the
most problematic situations that AD and related dementia
subjects are facing. It is also important to determine if
enforced isolation imposed specific issues related to the
severity of the cognitive disease. We know that AD and related
dementia neuropsychiatric symptoms, such as anxiety,
depression, sleep difficulties, among others, are extremely
frequent with a prevalence ranging from 60 to 80% and usually
imposed more troubling on caregivers than the cognitive
symptoms (14, 15). Sleep disturbances are reported in at least
30% of subjects with AD. Multifactorial contributors are
depression, anxiety, sedentarism, and adverse reactions from
medications (17). Standard nonpharmacologic proven strategies
to improve these disrupting symptoms and commonly used by
caregivers are maintaining a structured routine, reassuring
responses, physical exercise, sleep hygiene, and distraction.
Most of these strategies are difficult, almost impossible, to
implement during the quarantine (16).
Our objective was to measure in our setting the impact of
COVID-19 epidemic on the well-being and behavioral
symptoms of subjects at different stages of dementia living in
the community after the first 8 weeks of enforced isolation.MATERIALS AND METHODS
Family members of patients of the Aging and Memory Center of
FLENI with AD and related disorders were invited to participate
in our survey. Two physicians (MJR and GC) of the Aging and
Memory Center provided information about study´s aim and
distributed the questionnaire survey. Participation was voluntary
and anonymous. The survey sample consisted of family
caregivers (n = 119) of persons with AD or related dementia
living at home.
Survey
The survey had two main sections. The first one included
demographics of family members, paid caregivers, and
dementia subjects, and the other was composed of questions
regarding the challenges of care and management that subjects
and relatives experienced during the first 8 weeks of the
coronavirus quarantine in our setting. The survey was not
intended to replace a medical office visit or to make a clinicalAugust 2020 | Volume 11 | Article 866
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study with easy and quick to answer questions the psychological
issues that might had occurred during quarantine. A series of
questions were designed specifically to screen the onset or
worsening of behavioral symptoms (anxiety, insomnia, and
depression) or gait disturbances during the quarantine. We
specifically asked caregivers the following two questions for
each symptom inquired: “Did your relative with dementia
experience anxiety before the epidemic?” and “Do your relative
with dementia experience anxiety during the epidemic?” In order
to study if there was a change in the prescription of psychotropics
during quarantine, we asked caregivers specifically the following
questions. “During quarantine your relative needed the dose of the
following medications to be increased or to be started?” For each
of the following medications, we asked one specific question. The
list included: antipsychotics (quetiapine/risperidone/olanzapine),
anxiolytics (clonazepam, alprazolam, diazepam), non-
benzodiazepines hypnotics (zolpidem), and antidepressants
(citalopram, escitalopram, sertraline, venlafaxine, fluoxetine,
paroxetine, and trazodone). We did not record the exact dose of
the psychotropics, but the reported change in the dose of
the prescriptions.
A series of questions were made to assess the type and
setting of rehabilitation services that subjects where receiving
before the epidemic. We inquired specifically if subjects did
physical/occupational and cognitive rehabilitation and if it was
home based/at a day care center or specialized outpatient center.
We then asked if rehabilitation services had been discontinued
during the epidemic. We also asked if family members continued
or discontinued visiting subjects during the quarantine.
Patients
Patients were seen and studied extensively by a doctor specialized
in memory disorders before COVID-19 epidemic. Clinical
diagnosis of cognitive disorder syndromes was made based on
a detailed workup of history taking, medication review, physical
examination, neuroimaging, and neuropsychological tests.
Disease severity was based on Clinical Dementia Ration (CDR)
(18) score and functionality scales. All subjects had a longitudinal
follow up in the memory disorder clinic. Due to the unique
feature of isolation and quarantine in long term care facilities, we
decided to include in our sample only subjects living in the
community and excluded those living at long-term care settings.
Family and Paid Caregivers
We designed a visual analog scale to study the burden of care that
family members or paid caregivers experienced before and
during the epidemic. The question was: “How much stress
from 1 (low) to 3 (severe) do you feel by taking care of your
family member with dementia before the quarantine and during
quarantine?” We assigned 1 point for low, 2 points for
intermediate, and 3 points for severe burden of care. Our
intention was to measure the amount of burnout that a family
caregiver feels ranges across a continuum from none to an
extreme amount of stress. Based on the obtained score, the
results were transformed into three categories: low, medium,Frontiers in Psychiatry | www.frontiersin.org 3and high. The next step was to understand the main concerns
that family members were dealing with during quarantine in
relation to the care of subjects with dementia. We created a list of
six different hypothetical situations and asked family members to
select the main concern from that list.
Ethics
This study was presented and approved by the Medical Ethics
Committee of our center. The participation of this survey was
voluntary, and confidentiality of the dyad patient-family member
was preserved through all research stages and after. A letter was
mailed together with the questionnaire inviting family members
to participate in the survey and informing them of the purpose of
the research study.
Statistical Analysis
Statistical analyses were made using IBM SPSS 21 software
package. The characteristics of people with AD or related
dementia and their caregivers were analyzed with descriptive
statistics (percentages and means ± standard deviations). Chi-
square tests, with p < 0.01 were used to test differences between
family caregivers of persons in the mild stage and in severe stages
of dementia based on CDR (18) score. Behavioral symptoms and
covariates were analyzed with Spearman ’s rank-order
correlations. The level of burden of the family caregiver before
and during the COVID-19 epidemic was analyzed with paired-
samples t tests. To overcome some of the limitations imposed by
conventional pretest-posttest self-report measures, the
retrospective pretest-posttest design was utilized. We selected
this method since it has been shown to reduce response-shift
bias, p is convenient to implement and provides comparison data
in the absence of “pre” data.RESULTS
Our work is based on the data of a questionnaire survey collected
during the month of May of 2020, after approximately 8 weeks of
complete lockdown due to quarantine in Argentina.
Demographics and clinical characteristics of 119 subjects with
AD and related dementia and their family members are shown in
Table 1.
Characteristics of Subjects With Dementia
Baseline demographics were the following: Mean age of
subjects with dementia was 81.16 ± 7.03 years (a third of the
sample belonged to the eldest-old group of more than 85 years of
age), approximately a third were male, and mean number of
years of education was 13.26 ± 4.68. The most frequent diagnosis
was AD, followed by mixed AD, and then by vascular dementia.
The distribution of the staging of dementia was the following:
34% of the sample had mild dementia (CDR 1), 32% had
moderate dementia, and 34% had severe dementia with a CDR
score of 3.
Our main result was the report by family members of new
onset or exacerbation of pre-existing behavioral symptoms inAugust 2020 | Volume 11 | Article 866
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of anxiety, depression, and sleep disorders were reported in 33,
12.8, and 14.7% of the sample, respectively. Increasing gait
difficulties was reported in 40% of the sample. New onset of
behavioral symptoms or exacerbation of pre-existing behavioral
symptoms had a positive correlation with patient age and with
the presence of anxiety reported before the epidemic (r = 0.228,
p = 0.017 and r = 0.290, p = 0.002, Spearman, respectively) and a
negative correlation with the global CDR score (r = -0.289, p =
0.002, Spearman) and with the following domains of CDR:
memory (r = -0.202, p = 0.035, Spearman), community
affairs (r = -0.236, p = 0.013, Spearman), and home and
hobbies (r = -0.216, p = 0.024, Spearman).
Family members reported an overall increased use of
psychotropic medication during the epidemic with the following
distribution: 20% increased for antipsychotics, 15% for
benzodiazepines, 6% for hypnotics, and 10% for antidepressants.
In Table 2, we compared data according to the stages of
severity of dementia. We found significant differences in
increased behavioral symptoms of anxiety, insomnia, andTABLE 1 | Characteristics of participating caregivers and persons with
Alzheimer’s disease or related dementia.
Variables
Part I: Persons with dementia
Age, mean ± SD 81.16 ± 7.03
<65 years old, n (%) 2 (1.7)
65–85 years old, n (%) 85 (71.4)
≥85 years old, n (%) 32 (26.9)
Gender, male, n (%) 42 (35.3)
Education, mean ± SD 13.26 ± 4.68
Diagnosis, n (%)
AD 80 (67.2)
Mixed AD 26 (21.8)
Vascular dementia 7 (5.9)
Others 2 (1.7)
CDR, mean ± SD 1.99 ± 0.83
CDR 1, n (%) 40 (34.5)
CDR 2, n (%) 37 (31.9)
CDR 3, n (%) 39 (33.6)
Increased or onset of COVID-19-related anxiety, n (%) 50 (42)
Increased or onset of COVID-19-related insomnia, n (%) 34 (28.6)
Increased or onset of COVID-19-related depression, n
(%)
35 (29.4)
Increased gait problems during the COVID-19 pandemic,
n (%)
49 (41.2)
Increased or onset of COVID-19-related antipsychotics
prescription, n (%)
24 (20.2)
Increased or onset of COVID-19-related
benzodiazepines prescription, n (%)
18 (15.1)
Increased or onset of COVID-19-related hypnotics
prescription, n (%)
8 (6.7)
Increased or onset of COVID-19-related antidepressants
prescription, n (%)
12 (10.1)
Physical therapy, n (%)
At home 47 (39.5)
Specialized centers or Senior Day Care Center 24 (20.2)
No therapy 48 (40.3)
Occupational therapy, n (%)
At home 18 (15.1)
Specialized centers or Senior Day Care Center 12 (10.1)
No therapy 89 (74.8)
Cognitive Rehabilitation, n (%)
At home 21 (17.6)
Specialized centers or Senior Day Care Center 29 (24.4)
No therapy 69 (58)
Discontinued physical therapy during the COVID-
19 pandemic, n (%)
47/61 (76.9)
Discontinued occupational therapy during the COVID-
19 pandemic, n (%)
21 (91.3)
Discontinued cognitive rehabilitation during the COVID-
19 pandemic, n (%)
31/40 (77.5)
Part II: Family caregivers
Age, mean ± SD 58.61 ± 13.60
<45 years old, n (%) 17 (14.9)
45–65 years old, n (%) 64 (56.1)
65–85 years old, n (%) 30 (26.3)
≥85 years old, n (%) 3 (2.6)
Gender, male, n (%) 32 (28.1)
Education, mean ± SD 17.04 ± 5.15
Level of burden of the family caregiver prior to the
pandemic, mean ± SD
1.69 ± 0.67
Low burden, n (%) 51 (42.9)
Medium burden, n (%) 54 (45.4)
High burden, n (%) 14 (11.8)
(Continued)TABLE 1 | Continued
Variables
Level of burden of the family caregiver due to COVID-19,
mean ± SD
2.27 ± 0.72
Low burden, n (%) 19 (16)
Medium burden, n (%) 49 (41.2)
High burden, n (%) 51 (42.9)
Discontinued visit to a family member with dementia
during the COVID-19 pandemic, n (%)
41 (34.5)
Discontinued paid caregiver with dementia during the
COVID-19 pandemic, n (%)
27 (23.7)
Questions about supporting someone with dementia
during the coronavirus outbreak, n (%)
I’m concerned with how to handle disruptive behaviors while
we are quarantined at home
32 (31.1)
I’m not sure how I explain the situation to a person with
dementia?
11 (10.7)
I’m worried that my relative with dementia may worse during
COVID-19 quarantine.
9 (8.7)
I’m worried that the professional caregivers who come in to
help us might not be able to come.
13 (12.6)
I need to go outside to pick up supplies for my relative with
dementia but I am worried that I might catch the virus
27 (26.2)
I’m concerned that the caregiver is exhausted by the
quarantine
11 (10.7)
Part III: Paid caregivers
Paid caregiver, n (%) 40 (33.6)
Level of burden of the paid caregiver prior to the
pandemic, mean ± SD
1.35 ± 0.57
Low burden, n (%) 72 (69.9)
Medium burden, n (%) 26 (25.2)
High burden, n (%) 5 (4.9)
Level of burden of the paid caregiver due to COVID-19,
mean ± SD
1.55 ± 0.75
Low burden, n (%) 62 (60.2)
Medium burden, n (%) 25 (24.3)
High burden, n (%) 16 (15.5)August 2020 | VolumeThis table represents valid percentage of responses on the questionnaire survey
specifically designed for this study. The bold represents p < 0.05.
CDR, clinical dementia rating; AD, Alzheimer´s disease.11 | Article 866
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with a more advanced stage of dementia. These results were
showed in Figure 1. For psychotropics, we observed a non-
significant trend in increased prescription in the mild dementia
group (Table 2). Walking difficulties didn´t differ significantly
according to the disease severity.
Before the epidemic, the most commonly prescribed type of
rehabilitation was physical therapy (60% of the sample), followed
by cognitive rehabilitation in 42%, and by occupational therapy
in a lower percentage (25%) (Table 1). As expected, subjects with
more severe dementia received home-based physical therapy
(Table 2). There was a high rate of discontinuation of
rehabilitation during the epidemic: 76% discontinued physical
therapy, 91% occupational therapy, and 77% cognitive
rehabilitation. There was no statistical difference in the rate of
discontinuation based on the severity of dementia.Characteristics of Family Members and
Paid Caregivers
In Table 1, we showed the demographic characteristics of family
members and paid caregivers. The mean age of the family
members was 58.61 ± 13.60 years, 26% were older than 65
years of age, and 2% older than 85%. As expected, most family
members caring for patients were female. The mean education of
the family caregivers was 17.04 ± 5.15 years. Another aspect of
care that we wanted to study was the discontinuation of family
visits during the COVID-19 epidemic. We found that most
family members continued to visit their loved ones during
quarantine with a discontinuation rate of only 34%.
Overall, we observed an increased burden of care of family
members during the epidemic, independently of the dementia
severity. 12% of the family members felt that the burden of care
was severe before the epidemic, and this number increased to
42% during the epidemic. Thus, there was a significant difference
in the burnout scores before (M = 1.69, SD = 0.67) and during
(M = 2.27, SD = 0.72) the COVID-19 epidemic; t = -8,657, p <
0.001. When we analyzed the reasons for the increased family
burnout, we found interesting differences. Relatives of severe
dementia subjects were mainly concerned of the possibility of a
sick leave of paid caregivers, whereas relatives of subjects with
mild dementia were mainly concerned of the risk of COVID-19
transmission when assisting subjects in instrumental activities of
daily living.
Before the epidemic, 40% of the sample received care from a
paid caregiver. More severe cases tended to receive care from a
paid caregiver compared to milder cases. During the epidemic,
only 23% of the sample discontinued this service.DISCUSSION
This is a report of a survey of the well-being and aspects of care of
119 subjects living with dementia in the community and their
family caregivers in Argentina during the initial 8 weeks of
mandatory isolation due to COVID-19 epidemic.Frontiers in Psychiatry | www.frontiersin.org 5Our sample was composed of elderly subjects with dementia,
a third of those belonged to the very old group of elderly patients,
and a third of the sample were men. As expected to this age
group, the most frequent diagnosis was AD and followed by
mixed AD. The severity of the dementia was evenly distributed, a
third had mild disease, a third had intermediate disease, and a
third had severe disease.
Overall, we found worsening or new onset of behavioral
symptoms of anxiety, depression, and insomnia during the
enforced quarantine in subjects with dementia. There was a
positive correlation of these symptoms with advanced age and
with the presence of anxiety before this epidemic and a negative
correlation with the global CDR (18) score, community affairs,
and hobbies domain of CDR scale. Other findings were that most
family members continued family visits during the epidemic,
only a small proportion canceled caregiver paid services, and
most rehabilitation services were discontinued during
the epidemic.
Our findings are worrisome since behavioral and
psychological symptoms associated to dementia are a main
cause of deterioration of quality of life for patients and
caregivers, institutionalization, disability, increased use of
health resources and caregiver stress (15, 16). Longitudinal
studies of dementia subjects showed that these symptoms are
highly prevalent and persistent over time and can occur at any
point in the clinical course of the cognitive process (19, 20). Non-
pharmacologic management is consistently recommended in the
literature to control these symptoms due, in part, of the modest
efficacy and the potential of harm of pharmacologic therapy (16).
Caregiver training, keeping the patient active with a structured
personalized routine, taking the patient for a walk-in
neighborhood are all well-proven strategies to deal with
anxiety and agitation in patients with dementia (16).
Unfortunately, during enforce isolation, some of these
strategies were impossible to implement since Argentinian
authorities recommended that high-risk subjects with
comorbidities remain at home (2). Most forms of rehabilitation
interventions had been cancelled. Home-based interventions
were probably cancelled because of fear of letting a health care
professional enter patient’s home and increasing the risk of
spreading the epidemic. Outpatient rehabilitation services had
been cancelled as a direct effect of quarantine to avoid
unnecessary travel. Evidence from small trials in dementia
showed that cognitive training and rehabilitation could
improve cognition and decreased psychological symptoms. A
recent review of reviews showed that exercise improved
performance of daily activities in dementia (21). In our study,
most interventions were suspended, and there is probably a
relationship with the negative psychological issues found
during quarantine and the cancellation of rehabilitation services.
Another main finding of our research was that
neuropsychiatric symptoms during quarantine were more
frequent in subjects with mild dementia than in advanced
dementia cases. One possible explanation for this could be that
comparatively, mild dementia subjects might have suffered more
radical modification in their lifestyle habits during quarantineAugust 2020 | Volume 11 | Article 866
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Variables CDR T/c2 p
1 2 3
Part I: Persons with dementia
Age 3.861 0.425
<65 years old 50.00% 0.00% 50.00%
65–85 years old 38.10% 28.60% 33.30%
≥85 years old 23.30% 43.30% 33.30%
Gender, male 24.40% 31.70% 43.90% 3.868 0.145






AD 31.30% 32.50% 36.30%
Mixed AD 42.30% 34.60% 23.10%
Vascular dementia 42.90% 28.60% 28.60%
Others 0.00% 0.00% 100.00%
Increased or onset of COVID-19-related anxiety 35.40% 41.70% 22.90% 5.733 0.05
Increased or onset of COVID-19-related insomnia 44.10% 35.30% 20.60% 4.37 0.037
Increased or onset of COVID-19-related depression 42.90% 42.90% 14.30% 0.886 0.012
Increased gait problems during the COVID-19 pandemic 38.80% 32.70% 28.60% 0.423 0.809
Increased or onset of COVID-19-related antipsychotics prescription 33.30% 33.30% 33.30% 0.098 0.952
Increased or onset of COVID-19-related benzodiazepines prescription 27.80% 33.30% 38.90% 0.796 0.672
Increased or onset of COVID-19-related hypnotics prescription 12.50% 50.00% 37.50% 2.021 0.364
Increased or onset of COVID-19-related antidepressants prescription 41.70% 33.30% 25.00% 0.338 0.845
Physical therapy 13.003 0.011
At home 19.60% 30.40% 50.00%
Specialized centers or Senior Day Care Center 33.30% 37.50% 29.20%
No therapy 50.00% 30.40% 19.60%
Occupational therapy 5.595 0.232
At home 11.10% 38.90% 50.00%
Specialized centers or Senior Day Care Center 41.70% 33.30% 25.00%
No therapy 38.40% 30.20% 31.40%
Cognitive Rehabilitation 7.251 0.123
At home 28.60% 33.30% 38.10%
Specialized centers or Senior Day Care Center 48.30% 37.90% 13.80%
No therapy 30.30% 28.80% 40.90%
Discontinued physical therapy during the COVID-19 pandemic 25.50% 36.20% 38.30% 2.802 0.246
Discontinued occupational therapy during the COVID-19 pandemic 14.30% 42.90% 42.90% 4.65 0.098
Discontinued cognitive rehabilitation during the COVID-19 pandemic 29.00% 41.90% 29.00% 1.966 0.374
Part II: Family caregivers
Age 4.714 0.581
<45 years old 41.20% 17.60% 41.20%
45–65 years old 32.80% 36.10% 31.10%
65–85 years old 26.70% 36.70% 36.70%
≥85 years old 66.70% 0.00% 33.30%








Level of burden of the family caregiver prior to the pandemic 5.377 0.251
Low burden 35.30% 31.40% 33.30%
Medium burden 40.40% 30.80% 28.80%
High burden 7.70% 38.50% 53.80%
Level of burden of the family caregiver due to COVID-19 4,538 0.338
Low burden 47.40% 31.60% 21.10%
Medium burden 33.30% 25.00% 41.70%
High burden 30.60% 38.80% 30.60%
Discontinued visit to a family member with dementia during the COVID-19 pandemic 0.268 0.317 0.415 2.238 0.327
Discontinued paid caregiver with dementia during the COVID-19 pandemic 0.259 0.333 0.407 1.037 0.595
(Continued)Frontiers in Psychiatry | www.frontiersin.org 6 August 2020 | Volume 11 | Article 866
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homebound and less active.
Anxiety is reported in the literature to be strongly related to
impairment of activities of daily living and dependence. In our
sample, anxiety was the most frequently behavioral symptom
experienced by dementia subjects during quarantine, and it was
most frequently suffered by subjects with mild dementia. It is
possible that, during quarantine, these subjects had more
awareness of epidemic and risks of getting sick and that this
knowledge induced more anxiety.
Sleep disturbances are frequent in AD patients and are related
to age changes in sleep patterns, medication effects, comorbidity
with anxiety, depression, and to the neurodegenerative disease by
itself (18). Sleep disorders are disruptive to caregivers and
increase the rate of institutionalization and caregiver burnout
(22, 23). Strategies to improve sleep quality include sleep
hygiene, physical activity during the day, and keeping a
structured daily routine (22, 23). These strategies were all
compromised during this lockdown period, and sleep
difficulties were overall frequent, with even higher prevalence
in subjects with mild dementia. Specially in this population,
sedentary behavior during quarantine could had impacted on the
quality of sleep of subjects with mild dementia
Psychotropic medication use increased during quarantine,
independently of the dementia severity. Specifically use of
antipsychotics, benzodiazepines, hypnotics, and antidepressants
were more frequently prescribed. The first three medications are
included in the Beer´s list of potentially inappropriate
medication in elderly subjects with dementia (24). These
medications have the potential for cognitive decline and
increase the risk of falling and confusional state (24). Also,
antipsychotics in this vulnerable group increased the risk of
worse cardiovascular outcomes and are not currently
recommended (25). This increased in use of potentially
inappropriate medications in the elderly could cause in the
future a deleterious effect on the health status of the subjects in
our sample. A medication reconciliation plan once theFrontiers in Psychiatry | www.frontiersin.org 7quarantine ends with an active deprescribing strategy is one
possible strategy to mitigate this increased risk.
Another main finding of our study is that there was a
deterioration of the quality of walking during the quarantine.
Gait impairment is frequent in dementia patients, especially in
frail elderly subjects with advanced dementia, and is directly
related to the risk of falling and quality of life of the subjects
(26, 27). The performance of functional capacities depends on
the ability to ambulate (27). Walking deterioration during
quarantine is probably multifactorial, including discontinuation
of physical and cognitive rehabilitation, deconditioning related
to staying at home, and increased use of psychotropics as
described above.
Probably, one of the most important learnings of this
epidemic is the inclusion of technology for the evaluation and
monitoring of our patients at a distance, even in older adults.
While technology now is being used to socialize and give
emotional support and guidance to caregivers, cognitive and
physical exercise can be delivered via internet (28). It is true than
some individuals may struggle to use this technology (29), by
contrast, most caregivers usually can successfully use this
resource. A recent published randomized trial of a specialized
dementia care program delivered this way to the dyad patient-
caregiver showed improved quality of life, decreased caregiver
burn out and depression in those assigned to the active
intervention (30).
Our study’s main limitations are the relatively small size of
the sample and the lack of prospectively longitudinal follow-up.
Another pitfall is the lack of use of validated instruments to
measure caregiver burnout and behavioral and psychological
symptoms. We will continue to follow this cohort of subjects to
study the health consequences and the real impact after the
isolation period, and we will continue our research using
validated scales to measure these symptoms.
Our findings, in summary, showed the negative consequences
of quarantine in this sample of elderly patients. Individuals with
cognitive disorders are especially vulnerable during these timesTABLE 2 | Continued
Variables CDR T/c2 p
1 2 3
Questions about supporting someone with dementia during the coronavirus outbreak
I’m worried that the professional caregivers who come in to help us might not be able to come. 0.077 0.462 0.462 3.645 0.05
I need to go outside to pick up supplies for my relative with dementia but I am worried that I might catch
the virus
0.519 0.296 0.185 5.731 0.02
Part III: Paid Caregivers
Paid caregiver 22.50% 27.50% 50.00% 7.784 0.02
Level of burden of the paid caregiver prior to the pandemic, mean ± SD 7.464 0.113
Low burden 33.30% 36.20% 30.40%
Medium burden 26.90% 19.20% 53.80%
High burden 0.00% 60.00% 40.00%
Level of burden of the paid caregiver due to COV6ID-19, mean ± SD 3.588 0.465
Low burden 35.00% 35.00% 30.00%
Medium burden 20.80% 29.20% 50.00%
High burden 25.00% 31.30% 43.80%August 2020 | Volume 11 | ArticThis table represents valid percentage of responses on the questionnaire survey specifically designed for this study. The bold represents p < 0.05.le 866
Cohen et al. COVID-19 Epidemic in Subjects With Dementiaof isolation and epidemic, their care needs are not met, and social
engagement is decreased. Caregivers and patients need more
medical attention, support groups, and virtual modalities to deal
with worsened behavioral symptoms, caregiver stress and
burnout, walking abnormalities, and increased use of
psychotropics. In general, most office consults had been
cancelled, and caregiver have less contact and guidance with
specialized medical teams than before COVID-19. Physical social
distance required during the epidemic suspended interventions
that subjects with dementia constantly need due to the chronicFrontiers in Psychiatry | www.frontiersin.org 8nature of cognitive decline. Family member’s awareness of the
potential problems and a mitigation plan of action may help
families deal with the negative impact of this natural crisis.
Solutions will have to be creative, patient-centered, and flexible
to deal with the new changing scenario. More medical
counseling, guidance, and presence are needed urgently to help
this population deal with new serious health challenges arose
during the epidemic. Telehealth visits and telemedicine are a
priority, and it must be implemented on a regular basis to
provide frequent weekly medical counsel on specific newFIGURE 1 | This figure detailing valid percentage of responses on the questionnaire survey specifically designed for this study. (A) Percentage of patients with
increased or onset of anxiety during quarantine. (B) Percentage of patients with increased or onset of insomnia during quarantine. (C) Percentage of patients with
increased or onset of depression during quarantine.August 2020 | Volume 11 | Article 866
Cohen et al. COVID-19 Epidemic in Subjects With Dementiahealth issues related to this quarantine. Rehabilitation services
also will have to adapt to the new scenario, with reduced
occupancy of patients in the same area, among other strategies
(31). It is necessary to urgently develop a plan of action to help
dementia subjects and family members deal with the increased
stress that his epidemic imposed on them.DATA AVAILABILITY STATEMENT
The raw data supporting the conclusions of this article will be
made available by the authors, without undue reservation.ETHICS STATEMENT
The studies involving human participants were reviewed and
approved by FLENI. Ethics Committee. Written informed consentFrontiers in Psychiatry | www.frontiersin.org 9for participation was not required for this study in accordance with
the national legislation and the institutional requirements.AUTHOR CONTRIBUTIONS
The study was designed and conceived by GC, MR, JC, and RA.
Recruitment of participants and data collection were undertaken
by GC and MR. Statistical analysis was overseen by RA, and
analysis was undertaken by GC and MR. The manuscript was
prepared by GC and critically reviewed and approved by
all authors.ACKNOWLEDGMENTS
We would like to thank the caregivers and relatives who took
time to participate in this survey.REFERENCES
1. World Health Organization. Coronavirus disease 2019 (COVID- 19) Situation
Report – 51 March 11, 2020 . Available at: www.who.int/docs/default-source/
coronaviruse/situation- reports/20200311-sitrep-51-covid-19.pdf (Accessed
March 31, 2020).
2. Ministerio de la Nación. República Argentina. Decreto de Necesidad y urgencia
260/2020. Boletin Oficial de la República Argentina (2020). Number 34327.
Available at: www.boletinoficial.gob.ar.
3. Ministerio de la Nación. República Argentina. Situación COVID Argentian.
Reporte diario vespertino Numero 208. Downloads/29-06-2020-reporte-
vespertino-covid-10-pdf.
4. Brown E, Kumar S, Rajji TK, Pollock BG, Mulsant BH. Anticipating and
Mitigating the Impact of the COVID-19 Pandemic on Alzheimer’s Disease
and Related Dementias. The American journal of geriatric psychiatry : official
journal of the American Association for Geriatric Psychiatry 2020.S1064-
7481(20)30294-3. Am J Geriatr Psychiatry (2020) 28(7):712–21. doi: 10.1016/
j.jagp.2020.04.010
5. Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al.
Estimates of the severity of coronavirus disease 2019: a model-based analysis.
Lancet Infect Dis (2020) 20:1–9. doi: 10.1016/s1473-3099(20)30243-7
6. Emami A, Javanmardi F, Pirbonyeh NA, Akbari A. Prevalence of Underlying
Diseases in Hospitalized Patients with COVID-19: a Systematic Review and
Meta-Analysis. Arch Acad Emerg Med (2020) 8(1):e35.
7. Liu K, Chen Y, Lin R, Han KR. Clinical feature of COVID-19 in elderly
patients: A comparison with young and middle-aged patients. Eur Geriatr
Med (2020) 1–6. doi: 10.1016/j.jinf.2020.03.005
8. Cipriani G and Fiorino MD. Access to Care for Dementia Patients Suffering
From COVID-19. Am J Geriatric Psychiatry (2020) 28(7):796–7. doi: 10.1016/
j.jagp.2020.04.009. S1064-7481(20)30293-1.
9. Goodman-Casanova J, Dura-Perez E, Guzman-Parra J, Cuesta-Vargas A,
Mayoral-Cleries F. Telehealth Home Support During COVID-19
Confinement for Community-Dwelling Older Adults with Mild Cognitive
Impairment or Mild Dementia: Survey Study. J Med Internet Res (2020) 22(5):
e19434. doi: 10.2196/19434
10. Austrom MG, Boustani M, Lamantia MA. Ongoing Medical Management to
Maximize Health and Well-being for Persons Living with Dementia.
Gerontologist (2018) 58(2014):S48–57. doi: 10.1093/geront/gnx147
11. Wang H, Li T, Barbarino P, Gauthier S, Brodaty H, Molinuevo JL, et al.
Dementia care during COVID-19. Lancet (Lond Engl) (2020) 395
(10231):1190–1. doi: 10.1016/S0140-6736(20)30755-812. Bojdani E, Rajagopalan A, Chen A, Gearin P, Olcott W, Shankar V, et al.
COVID-19 Pandemic: Impact on psychiatric care in the United States.
Psychiatry Res (2020) 289:113069. doi: 10.1016/j.psychres.2020.113069
13. Pachana NA, Beattie E, Byrne GJ, Brodaty H. COVID-19 and psychogeriatrics: the
view fromAustralia. Int Psychogeriatr (2020) 1–7. doi: 10.1017/S1041610220000885
14. Mega MS, Cummings JL, Fiorello T. Gornbein J. The spectrum of behavioral
changes in Alzheimer’s disease. Neurology (1996) 46(1):130. doi: 10.1212/
WNL.46.1.130
15. Hughes TB, Black BS, Albert MM, Glitin L,. Correlates of objective and
subjective measures of caregiver burden among dementia caregivers: influence
of unmet patient and caregiver dementia-related care needs. Int Psychogeriatr
(2014) 26(11):1875–83. doi: 10.1017/S1041610214001240
16. Livingston G, Kelly L, Lewis-Holmes E, Baio G, Morris S, Patel N, et al. Non-
pharmacological interventions for agitation in dementia: systematic review of
randomized controlled trials. Br J Psychiatry (2014) 205(6):436–42.
doi: 10.1192/bjp.bp.113.141119
17. Bliwise DL. Sleep disorders in Alzheimer’s disease and other dementias. Clin
Cornerstone (2004) 6(Suppl 1A):S16. doi: 10.1016/S1098-3597(04)90014-2
18. Hughes C, Berg L, Danziger W, Coben L, Martin R. A new clinical scale for the
staging of dementia. Br J Psychiatry (1982) 140:566–72. doi: 10.1192/bjp.140.6.566
19. Savva GM, Zaccai J, Matthews FE, Davidson E, McKeith I, Brayne C, et al.
Prevalence, correlates and course of behavioural and psychological symptoms
of dementia in the population. Br J Psychiatry (2009) 194(3):212–9.
doi: 10.1192/bjp.bp.108.049619
20. Van der Linde RM, Dening T, Stephan BC, Prina AM, Evans E, Brayne C.
Longitudinal course of behavioural and psychological symptoms of dementia:
systematic review. Br J Psychiatry (2016) 209(5):366–77. doi: 10.1192/bjp.bp.114.148403
21. Laver K, Dyer S, Whitehead C, Clemson L, Crotty M. Interventions to delay
functional decline in people with dementia: a systematic review of systematic
reviews. BMJ Open (2016) 6:e010767. doi: 10.1136/bmjopen-2015-010767
22. Phan S, Osae S, Morgan J, Inyang M, Fagan. Neuropsychiatric Symptoms in
dementia considerations for Pharmacotherapy in the USA. Drugs RD (2019)
19(2):93–115. doi: 10.1007/s40268-019-0272-1
23. Vitiello MV, Borson S. Sleep disturbances in patients with Alzheimer’s disease:
epidemiology, pathophysiology and treatment. CNS Drugs (2001) 15(10):777–
96. doi: 10.2165/00023210-200115100-00004
24. American Geriatrics Society. Updated AGS Beers Criteria® for Potentially
Inappropriate Medication Use in Older Adults. J Am Geriatr Soc (2019)
67:674–94. doi: 10.1111/jgs.15767
25. Wang J, Yu JT, Wang HF, Meng X.-F, Wang C, Tan C-C, et al. Pharmacological
treatment of neuropsychiatric symptoms in Alzheimer’s disease: a systematicAugust 2020 | Volume 11 | Article 866
Cohen et al. COVID-19 Epidemic in Subjects With Dementiareview and meta-analysis. J Neurol Neurosurg Psychiatry (2015) 86(1):101–9.
doi: 10.1136/jnnp-2014-308112
26. Portet F, Scarmeas N, Cosentino S, Helzner EP, Stern Y. Extrapyramidal signs
before and after diagnosis of incident Alzheimer disease in a prospective population
study. Arch Neurol (2009) 66(9):1120–6. doi: 10.1001/archneurol.2009.196
27. Allan LM, Ballard CG, Rowan EN, Kenny RA. Incidence and Prediction of
Falls in Dementia: A ProspectivestudyinOlderPeople. PloSON (2009) 4(5):
e5521. doi: 10.1371/journal.pone.0005521
28. Eghtesadi M. Breaking social isolation amidst Covid-19: a viewpoint on
improving access to technology in long term care facilities. J Am Geriatr
Soc (2020) 68:949–50. doi: 10.1111/jgs.16478E
29. Brooks SK, Webster R, Smith L, Woodland L, Wessely S, Greenberg , et al. The
psychological impact of quarantine and how to reduce it: rapid review of the
evidence. Lancet (2020) 395(10227):912–20. doi: 10.1016/S0140-6736(20)
30460-8
30. Possin KL, Merrilees JJ, Dulaney S, Bonasera SJ, Chiong W, Lee K, et al. Effect
of Collaborative Dementia Care via Telephone and Internet on Quality of Life,Frontiers in Psychiatry | www.frontiersin.org 10Caregiver Well-being, and Health Care Use: The Care Ecosystem Randomized
Clinical Trial. JAMA Intern Med (2019) 179(12):1658–67. doi: 10.1001/
jamainternmed.2019.4101
31. Leocani L, Diserens K, Moccia M, Caltagirone C. Disability through COVID‐
19 pandemic: neurorehabilitation cannot wait. Eur J Neuro (2020) 27:e50–1.
doi: 10.1111/ene.14320
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Cohen, Russo, Campos and Allegri. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice. No
use, distribution or reproduction is permitted which does not comply with these terms.August 2020 | Volume 11 | Article 866
